Making the switch to metabolic health.
The fate of cells—their future identity or the identity of daughter cells after division—is largely controlled by their source of energy.
Changing the fate of cells requires the ability to provide them with a new source of energy.
Comet Therapeutics is developing the MetaSwitch™ Platform, which generates a novel class of small molecules with the ability to reprogram cellular metabolism. Using precursors of natural and novel metabolites, Comet is pioneering the use of metabolic switches to alter cell’s energy sources.
With this ability to up-regulate or down-regulate cellular metabolism and activity, Comet is developing experimental medicines with unique power to alter the fate of cells – and influence the course of numerous diseases characterized by metabolism dysfunction. We are making the switch to metabolic health.